benzoxazoles has been researched along with Stomach Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, NH; Kim, SN; Kim, YK; Lee, S; Oh, JS | 1 |
| Choi, MJ; Hong, SS; Hong, SW; Jung, KH; Kang, NS; Lee, HS; Lee, J; Park, BH; Yun, JI; Zheng, HM | 1 |
2 other study(ies) available for benzoxazoles and Stomach Neoplasms
| Article | Year |
|---|---|
Anti-mitotic potential of 7-diethylamino-3(2'-benzoxazolyl)-coumarin in 5-fluorouracil-resistant human gastric cancer cell line SNU620/5-FU.
Topics: Antimetabolites, Antineoplastic; Antimitotic Agents; Apoptosis; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Resistance, Neoplasm; Fluorouracil; Humans; Stomach Neoplasms; Tubulin Modulators | 2012 |
KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Topics: Aminopyridines; Angiogenesis Inhibitors; Animals; Antigens, CD34; Apoptosis; Benzoxazoles; Caspase 3; Cell Line, Tumor; Cell Proliferation; DNA Fragmentation; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Human Umbilical Vein Endothelial Cells; Humans; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Molecular; Molecular Structure; Neovascularization, Physiologic; Phosphatidylinositol 3-Kinase; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Rats; Rats, Sprague-Dawley; Signal Transduction; Stomach Neoplasms; Time Factors; Tissue Culture Techniques; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |